CD19 Polyclonal Antibody bs-0079R from Bioss Inc.

Product Specs
ItemCD19 Polyclonal Antibody
CompanyBioss Inc.
Price $375.00Supplier Page View Company Product Page
Catalog Numberbs-0079R
Molecular Weight61kDa
ImmunogenKLH conjugated peptide, rat CD19
Conjugate/TagUnconjugated
ApplicationsIHC, IHC-P, ELISA, FCM, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC), IF(ICC)
IsotypeIgG
ReactivityHuman, Mouse, Rat, Sheep, Rat, Mouse
Quantity100ul, 20uL
ClonalityPolyclonal
Antibody TypePrimary Antibody
Format0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol
TargetCD19
HostRabbit
Concentration1ug/ul
NCBI Full Gene NameCD19 antigen
TissueBlood, Kidney

Questions and Answers

Can this antibody be used for immunohistochemistry in mouse models?

Yes, the CD19 Polyclonal Antibody has been utilized in immunohistochemistry applications, as demonstrated in the study by Takemiya et al. (2017), where it was used to label CD4-positive T cells in the spinal cords of mice during experimental autoimmune encephalomyelitis.

What species can I expect this antibody to react with in my experiments?

The CD19 Polyclonal Antibody is reactive with multiple species, including human, mouse, rat, and sheep, making it versatile for various experimental setups involving these organisms.

Is there any evidence of this antibody being effective in flow cytometry applications?

While specific publications detailing the use of the CD19 Polyclonal Antibody in flow cytometry are not provided, its applications include flow cytometry, suggesting it has been shown to work in this context. Researchers should consider validating its performance in their specific experimental conditions.

How does this antibody function in relation to B-lymphocyte activation?

The CD19 Polyclonal Antibody assembles with the antigen receptor of B-lymphocytes, which decreases the threshold for antigen receptor-dependent stimulation, thereby enhancing B-cell activation and response. This mechanism is crucial for understanding B-cell biology and its implications in immune responses.

Bioss Inc.

300 Tradecenter Drive

Suite 4610

Woburn, MA 01801

United States

Phone: 800.501.7654 (Toll free)
Phone: +1.781.569.5821 (International)

Email: info@biossusa.com
orders@biossusa.com
support@biossusa.com
sales@biossusa.com

Company Profile

Website: www.biossusa.com

(1) Antileukemic Effect of Palladium Nanoparticles Mediated by White Tea (Camellia sinensis) Extract In Vitro and in WEHI-3B-Induced Leukemia In VivoEvidence-Based Complementary and Alternative MedicineAugust 19, 2020Hemn Othman, Heshu Rahman, Syam Mohan, Sadat Aziz, Hardi Marif, Dianne Ford, Nozlena Abdulsamad, Kawa Amin, Rasedee Abdullahantibody (T-lymphocyte marker) (Abcam ab5690, UK) or CD19 primary antibody (B-lymphocyte marker) (Bioss bs0079R, USA) at 4°C overnight. After washing with TBST, sections were incubated for 45 min with labeled polymer-HRP

(2) Digital gene expression analyses of mammary glands from meat ewes naturally infected with clinical mastitisRoyal Society open scienceJuly 1, 2019Li T, Gao J, Zhao X, Ma Y.

(3) Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary FibrosisAmerican journal of respiratory cell and molecular biologyFebruary 1, 2018Goodwin J, Choi H, Hsieh MH, Neugent ML, Ahn JM, Hayenga HN, Singh PK, Shackelford DB, Lee IK, Shulaev V, et al.

(4) Microsomal Prostaglandin E Synthase-1 Facilitates an Intercellular Interaction between CD4⁺ T Cells through IL-1β Autocrine Function in Experimental Autoimmune EncephalomyelitisInternational journal of molecular sciencesDecember 19, 2017Takemiya T, Takeuchi C, Kawakami M.#550278, 1:50), or anti-CD19 (Thermo Fisher, Waltham, MA, USA, #14-0194-82, 1:100; Bioss, Woburn, MA, USA, bs-0079R, 1:100) antibodies. After removal of the primary antibody, the sections were incubated with FITC-labeled

(5) The effects of allogenic stem cells in a murine model of hind limb diabetic ischemic tissuePeerJAugust 21, 2017Jesús Álvarez García, Soledad García Gómez-Heras, Luis Riera del Moral, Carlota Largo, Damián García-Olmo, Mariano García-Arranz1:100 dilution, anti-CD206 polyclonal antibody orb180464, Biorbyt) at 1:100 dilution and anti-CD19 (BS-0079R; Bioss, Woburn, MA, USA) at 1:500 dilution. The sections were subsequently incubated with biotinylated

(6) Morinda Citrifolia Leaf Extract Ameliorated Leukemia in Mice ModelJournal of Applied Biotechnology & BioengineeringApril 17, 2017Suhaila Mohamedantibody (T-lymphocyte marker) (Abcam ab5690, UK) or CD19 primary antibody (B-lymphocyte marker) (Bioss bs0079R, USA) reagents was applied to the section and incubated in a humidity chamber at room temperature for

(7) Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical ModelTransplantationSeptember 1, 2015Reese SR, Wilson NA, Huang G, Redfield RR 3rd, Zhong W, Djamali A

Be the First to Write a Review!

FCM

CD19 Polyclonal Antibody

WB

CD19 Polyclonal Antibody from Bioss Inc.

Description

Questions and Answers

Bioss Inc.

Citations (7)

Reviews

CD19 Polyclonal Antibody from Bioss Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map